Goldman Sachs Group Inc. is considering sweetening the terms on $1.73 billion of leveraged loans tied to chemical maker Arclin Inc.’s acquisition of DuPont de Nemours Inc.’s Aramids business.
Goldman Sachs Group Inc. is considering sweetening the terms on $1.73 billion of leveraged loans tied to chemical maker Arclin Inc.’s acquisition of DuPont de Nemours Inc.’s Aramids business.
The bank is weighing a higher interest rate and a lower is… [315 chars]
Source: Bloomberg | Published: 2026-02-20T22:11:12Z
Credit: Bloomberg
